Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis.
母体免疫球蛋白 A 控制新生儿微生物群和坏死性小肠结肠炎发展的机制。
基本信息
- 批准号:10312104
- 负责人:
- 金额:$ 44.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-01-15 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAffectAnimal ModelAnti-Bacterial AgentsAntibodiesAntibody RepertoireAreaAsthmaB-LymphocytesBacteriaBenignBindingCause of DeathCellsChildChronic DiseaseCommunitiesDangerousnessDataDevelopmentDiseaseDropsEnterobacteriaceaeEpithelialGenerationsGenetic TranscriptionGnotobioticHealthHeterogeneityHuman MilkImmuneImmune responseImmune systemImmunoglobulin AIncidenceIndividualInfantInfectionInfection preventionInfiltrationInflammatoryIntestinal DiseasesIntestinal MucosaIntestinesKnowledgeLeadLinkMammary glandMaternal antibodyMeasuresMediatingMilkMilk BanksMothersMucosal Immune ResponsesMucous MembraneMusMutationNecrotizing EnterocolitisNeonatalObesityPremature InfantPremature Infant DiseasesPreventive therapyProductionPropertyRag1 MouseResearchRiskRoleSamplingSecretory Immunoglobulin ASepsisShapesSourceStructureT-LymphocyteTaxonTestingTherapeuticVariantWomanbacterial communitybacterial genome sequencingbasecostde novo mutationdonor milkgut microbiotahost microbiotaimprovedintestinal epitheliummicrobial communitymicrobiomemicrobiotamouse modelneonatal miceneonatenovelpathogenprematurepreventprospectiveprotective effectpupresponsetranscriptome
项目摘要
Abstract
Neonates are particularly susceptible to invasion by colonizing bacteria and thus mammalian mothers protect
their children via antibodies and in particular, Immunoglobulin A (IgA), secreted into maternal milk. Necrotizing
Enterocolitis (NEC) is a disease of premature infants characterized by invasion of the neonatal intestine by the
microbiota. Studies have shown that the incidence of NEC is significantly reduced in infants fed with breast milk,
though the mechanism is unclear. Our preliminary studies show that maternal IgA (mIgA) is an important factor
in protection against NEC. Analysis of IgA-binding on fecal samples from premature infants indicated that breast
milk was the predominant source of IgA in the first month post-delivery and that a relative drop in the fraction of
bacteria bound by IgA is associated with the development of NEC. Sequencing of IgA-bound and unbound
bacteria indicated that NEC was associated with a unique increase in IgA negative Enterobacteriaceae. Further,
we confirmed that IgA is critical in preventing NEC in the murine model, where we demonstrate that pups reared
by mIgA deficient mothers are susceptible to disease, indicating that IgA in breast milk is necessary for
protection. Together these data indicate that mIgA binding is critical in preventing the development of NEC by
shaping the neonatal microbiota. In order to mediate effects on bacterial communities IgA acts on bacterial sub-
populations. Therefore, our central hypothesis is that IgA in maternal milk modifies intestinal bacteria directly,
preventing their invasion of the neonatal intestine and the induction of inflammatory immune responses. We will
test this hypothesis in three aims. In the first aim we will investigate the mechanisms of how individual sub-
populations of Enterobacteriaceae change to elude mIgA. Further we will investigate the mIgA repertoire of
different breast milk donors to test the hypothesis that variation in this repertoire is important in binding different
intestinal bacteria. In aim 2 we will investigate the mechanism of IgA binding on the neonatal microbiota at the
community level, via 16S rRNA gene sequencing and by transcriptional analysis of a model organism in
gnotobiotic mice. Our hope is to associate these data with analysis of the role of IgA on epithelial association of
intestinal bacteria and the downstream immune responses that are induced. In the third aim we will investigate
whether the production of mammary gland antibodies that protect against NEC are dependent upon maternal T
cells. These aims will lead to a better understanding of how mIgA shapes the nascent microbiome and the
neonatal immune response. In addition, our proposal may improve provide strategies to prevent NEC via the
targeted provision of breast milk containing protective antibodies to the most at-risk children.
抽象的
新生儿特别容易受到定植细菌的入侵,因此哺乳动物母亲会保护它们
他们的孩子通过抗体,特别是免疫球蛋白 A (IgA),分泌到母乳中。坏死
小肠结肠炎 (NEC) 是一种早产儿疾病,其特征是新生儿肠道受到结肠炎的侵袭。
微生物群。研究表明,母乳喂养的婴儿NEC的发病率显着降低,
虽然机制尚不清楚。我们的初步研究表明,母体 IgA (mIgA) 是一个重要因素
针对 NEC 的保护。对早产儿粪便样本的 IgA 结合分析表明,母乳
产后第一个月,牛奶是 IgA 的主要来源,并且 IgA 比例相对下降
IgA 结合的细菌与 NEC 的发生有关。 IgA 结合和未结合的测序
细菌表明 NEC 与 IgA 阴性肠杆菌科细菌的独特增加有关。更远,
我们在小鼠模型中证实了 IgA 对于预防 NEC 至关重要,我们证明了饲养的幼崽
缺乏 mIgA 的母亲容易患病,这表明母乳中的 IgA 是婴儿出生所必需的。
保护。这些数据共同表明 mIgA 结合对于预防 NEC 的发展至关重要
塑造新生儿微生物群。为了介导对细菌群落的影响,IgA 作用于细菌亚群
人口。因此,我们的中心假设是母乳中的 IgA 直接改变肠道细菌,
防止它们侵入新生儿肠道并诱导炎症免疫反应。我们将
从三个目标检验这一假设。在第一个目标中,我们将研究个体如何子化的机制
肠杆菌科菌群发生变化以逃避 mIgA。我们将进一步研究 mIgA 的全部功能
不同的母乳捐赠者来检验这一假设,即该库的变异对于结合不同的母乳捐赠者很重要
肠道细菌。在目标 2 中,我们将研究 IgA 与新生儿微生物群结合的机制
群落水平,通过 16S rRNA 基因测序和模式生物的转录分析
限生小鼠。我们希望将这些数据与 IgA 对上皮细胞关联的作用分析联系起来。
肠道细菌和诱导的下游免疫反应。在第三个目标中,我们将调查
预防 NEC 的乳腺抗体的产生是否依赖于母体 T
细胞。这些目标将有助于更好地了解 mIgA 如何塑造新生微生物组和
新生儿免疫反应。此外,我们的建议可能会改进提供策略,通过
有针对性地向高危儿童提供含有保护性抗体的母乳。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy Wesley Hand其他文献
Timothy Wesley Hand的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy Wesley Hand', 18)}}的其他基金
Investigating the tissue location and protective function of oral vaccine-specific tissue resident memory CD4 T cells
研究口服疫苗特异性组织驻留记忆 CD4 T 细胞的组织定位和保护功能
- 批准号:
10646930 - 财政年份:2023
- 资助金额:
$ 44.97万 - 项目类别:
Identifying the mechanism of anti-colorectal immunity induced by mucoinvasive colonic bacteria
确定粘膜侵袭性结肠细菌诱导的抗结直肠免疫机制
- 批准号:
10585344 - 财政年份:2022
- 资助金额:
$ 44.97万 - 项目类别:
Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis.
母体免疫球蛋白 A 控制新生儿微生物群和坏死性小肠结肠炎发展的机制。
- 批准号:
9883292 - 财政年份:2020
- 资助金额:
$ 44.97万 - 项目类别:
Mechanisms of maternal Immunoglobulin A control over the neonatal microbiota and the development of Necrotizing Enterocolitis.
母体免疫球蛋白 A 控制新生儿微生物群和坏死性小肠结肠炎发展的机制。
- 批准号:
10541105 - 财政年份:2020
- 资助金额:
$ 44.97万 - 项目类别:
相似国自然基金
肾—骨应答调控骨骼VDR/RXR对糖尿病肾病动物模型FGF23分泌的影响及中药的干预作用
- 批准号:82074395
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
基于细胞自噬调控的苦参碱对多囊肾小鼠动物模型肾囊肿形成的影响和机制研究
- 批准号:
- 批准年份:2019
- 资助金额:33 万元
- 项目类别:地区科学基金项目
靶向诱导merlin/p53协同性亚细胞穿梭对听神经瘤在体生长的影响
- 批准号:81800898
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
伪狂犬病病毒激活三叉神经节细胞对其NF-кB和PI3K/Akt信号转导通路影响的分子机制研究
- 批准号:31860716
- 批准年份:2018
- 资助金额:39.0 万元
- 项目类别:地区科学基金项目
基于中枢胰岛素抵抗探讨自噬失调对肾虚阿尔茨海默的影响及机制研究
- 批准号:81803854
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
相似海外基金
MECHANISMS OF VISCERAL PAIN DRIVEN BY SMALL INTESTINAL MICROBIOTA
小肠微生物驱动内脏疼痛的机制
- 批准号:
10836298 - 财政年份:2023
- 资助金额:
$ 44.97万 - 项目类别:
Capsular locus deep sequencing to study Klebsiella populations
荚膜位点深度测序研究克雷伯氏菌种群
- 批准号:
10679308 - 财政年份:2023
- 资助金额:
$ 44.97万 - 项目类别:
Effects of air pollution/maternal stress on microglial sculpting of social circuits
空气污染/母亲压力对社会回路小胶质细胞塑造的影响
- 批准号:
10748065 - 财政年份:2023
- 资助金额:
$ 44.97万 - 项目类别:
The role of dietary cholesterol in Nonalcoholic fatty liver disease through the action of gut microbiota
膳食胆固醇通过肠道微生物群的作用在非酒精性脂肪肝中的作用
- 批准号:
10751526 - 财政年份:2023
- 资助金额:
$ 44.97万 - 项目类别:
Development of a Novel Therapeutic for Mitigating Radiation-Induced Microbiome Dysbiosis and Acute Gastrointestinal Syndrome
开发一种缓解辐射引起的微生物群失调和急性胃肠道综合症的新疗法
- 批准号:
10567515 - 财政年份:2023
- 资助金额:
$ 44.97万 - 项目类别: